Oxford company PalaeoPi launches to offer automated 3D digitisation of objects
The Oxford University spinout will be offering automated photogrammetry to the archaeology and heritage markets.
OMass raises £14m to boost drug development programme
The Oxford University spinout plans to use the investment to fuel its structural mass spectrometry to identify new medicines.
Oxford firm launches to develop quantum-era sensor technology
Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current counterparts.
Oxford University Innovation Q3 2018 Update
Oxford spinouts secure £130m in August alone as OUI heads towards a potentially record breaking year for spinout generation.
Oxford firm launches to predict and prevent heart attacks years before they happen
Oxford University spinout Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques.
Regenerative medicine spinout OxStem launches subsidiaries to tackle diabetes and inflammation
Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.
Oxford University Innovation launches social enterprise support
Oxford University Innovation unveils support for impact-driven businesses from academic ideas.
Oxford VR raises £3.2m for development of VR psychological therapies
The University of Oxford spinout also inks clinical paper in Lancet Psychiatry, appoints CEO and sets up Oxford HQ and London development hub.
Industry veteran appointed as Chief Scientific Officer of OxStem Ltd
Dr. Georg C. Terstappen has been appointed to the role of Chief Scientific Officer (CSO) of spinout OxStem Ltd.
Evox Therapeutics secures £35.5m Series B
The Oxford University spinout will use the investment to further develop its exosome technology, capable of delivering drugs to previously inaccessible parts of the body.
